{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T06:10:00Z","timestamp":1780380600634,"version":"3.54.1"},"reference-count":181,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>The breach of an interspecies barrier by RNA viruses has facilitated the emergence of lethal hCoVs, particularly SARS-CoV-2, resulting in significant socioeconomic setbacks and public health risks globally in recent years. Moreover, the high evolutionary plasticity of hCoVs has led to the continuous emergence of diverse variants, complicating clinical management and public health responses. Studying the evolutionary trajectory of hCoVs, which provides a molecular roadmap for understanding viruses\u2019 adaptation, tissue tropism, spread, virulence, and immune evasion, is crucial for addressing the challenges of zoonotic spillover of viruses. Tracing the evolutionary trajectory of lethal hCoVs provides essential genomic insights required for risk stratification, variant\/sub-variant classification, preparedness for outbreaks and pandemics, and the identification of critical viral elements for vaccine and therapeutic development. Therefore, this review examines the evolutionary landscape of the three known lethal hCoVs, presenting a focused narrative on SARS-CoV-2 variants under monitoring (VUMs) as of May 2025. Using advanced bioinformatics approaches and data visualization, the review highlights key spike protein substitutions, particularly within the receptor-binding domain (RBD), which drive transmissibility, immune escape, and potential resistance to therapeutics. The article highlights the importance of real-time genomic surveillance and intervention strategies in mitigating emerging variant\/sub-variant risks within the ongoing COVID-19 landscape.<\/jats:p>","DOI":"10.3390\/biomedicines13102450","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T12:04:52Z","timestamp":1759925092000},"page":"2450","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evolutionary Insight into Fatal Human Coronaviruses (hCoVs) with a Focus on Circulating SARS-CoV-2 Variants Under Monitoring (VUMs)"],"prefix":"10.3390","volume":"13","author":[{"given":"Mohammad Asrar","family":"Izhari","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Faculty of Applied Medical Sciences, Al-Baha University, Al-Baha 65528, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4724-5337","authenticated-orcid":false,"given":"Fahad","family":"Alghamdi","sequence":"additional","affiliation":[{"name":"Laboratory Department, Prince Meshari Bin Saud Hospital, Al-Baha 65639, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Essa Ajmi","family":"Alodeani","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Al-Kharj Military Hospital, Al-Kharj 11361, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad A.","family":"Salem","sequence":"additional","affiliation":[{"name":"Sabt Al Alaya General Hospital, Sabt Al Alayah 67512, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahamad H. A.","family":"Almontasheri","sequence":"additional","affiliation":[{"name":"Ibn Sina Hospital for Extended Care, Makkah 24211, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daifallah M. M.","family":"Dardari","sequence":"additional","affiliation":[{"name":"Laboratory Department, Baish General Hospital, Jazan 87597, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansour A. A.","family":"Hadadi","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Specialized Hospital, Jazan 87597, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed R. A.","family":"Gosady","sequence":"additional","affiliation":[{"name":"Laboratory Department, Baish General Hospital, Jazan 87597, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael A.","family":"Alghamdi","sequence":"additional","affiliation":[{"name":"Laboratory Department, King Fahad Hospital Al-Baha, AI-Baha 65732, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bakheet A.","family":"Alzahrani","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Faculty of Applied Medical Sciences, Al-Baha University, Al-Baha 65528, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bandar M. A.","family":"Alzahrani","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Faculty of Applied Medical Sciences, Al-Baha University, Al-Baha 65528, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s12276-021-00604-z","article-title":"On the origin and evolution of SARS-CoV-2","volume":"53","author":"Singh","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Shen, L., and Gu, X. (2016). Evolutionary Dynamics of MERS-CoV: Potential Recombination, Positive Selection and Transmission. Sci. Rep., 6.","DOI":"10.1038\/srep25049"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Hussain, B., and Wu, C. (2024). Evolutionary and Phylogenetic Dynamics of SARS-CoV-2 Variants: A Genetic Comparative Study of Taiyuan and Wuhan Cities of China. Viruses, 16.","DOI":"10.20944\/preprints202404.1459.v1"},{"key":"ref_4","first-page":"102","article-title":"Infection with Middle East respiratory syndrome coronavirus","volume":"51","author":"Alsolamy","year":"2015","journal-title":"Can. J. Respir. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-022-05522-2","article-title":"The WHO estimates of excess mortality associated with the COVID-19 pandemic","volume":"613","author":"Msemburi","year":"2023","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1016\/S2468-2667(20)30263-2","article-title":"Effect of internationally imported cases on internal spread of COVID-19: A mathematical modelling study","volume":"6","author":"Russell","year":"2021","journal-title":"Lancet Public Health"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"105246","DOI":"10.1016\/j.jcv.2022.105246","article-title":"Human coronaviruses: Origin, host and receptor","volume":"155","author":"Tang","year":"2022","journal-title":"J. Clin. Virol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e64509","DOI":"10.7554\/eLife.64509","article-title":"Evidence for adaptive evolution in the receptor-binding domain of seasonal coronaviruses OC43 and 229e","volume":"10","author":"Kistler","year":"2021","journal-title":"Elife"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e28861","DOI":"10.1002\/jmv.28861","article-title":"Continuous evolution and emerging lineage of seasonal human coronaviruses: A multicenter surveillance study","volume":"95","author":"Ye","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/infdis\/jiaa185","article-title":"Epidemiology of Seasonal Coronaviruses: Establishing the Context for the Emergence of Coronavirus Disease 2019","volume":"222","author":"Nickbakhsh","year":"2020","journal-title":"J. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/jamainternmed.2019.7495","article-title":"Empirical anti-MRSA vs standard antibiotic therapy and risk of 30-day mortality in patients hospitalized for pneumonia","volume":"180","author":"Jones","year":"2020","journal-title":"JAMA Intern. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3390\/pathophysiology29030032","article-title":"Pathophysiology of methicillin-resistant Staphylococcus aureus superinfection in COVID-19 patients","volume":"29","author":"Habib","year":"2022","journal-title":"Pathophysiology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"100794","DOI":"10.1016\/j.drup.2021.100794","article-title":"An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment","volume":"59","author":"Rosik","year":"2021","journal-title":"Drug Resist. Updates"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"6491738","DOI":"10.1155\/2019\/6491738","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV): Infection, immunological response, and vaccine development","volume":"2019","author":"Mubarak","year":"2019","journal-title":"J. Immunol. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jiph.2021.12.014","article-title":"The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges","volume":"15","author":"Malik","year":"2022","journal-title":"J. Infect. Public Health"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/j.mayocp.2020.07.021","article-title":"SARS-CoV-2 vaccine development: Current status","volume":"95","author":"Poland","year":"2020","journal-title":"Mayo Clin. Proc."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/ane.13550","article-title":"Neurological side effects of SARS-CoV-2 vaccinations","volume":"145","author":"Finsterer","year":"2022","journal-title":"Acta Neurol. Scand."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1473-3099(21)00224-3","article-title":"Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: A prospective observational study","volume":"21","author":"Menni","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"100253","DOI":"10.1016\/j.lanepe.2021.100253","article-title":"Adverse events of active and placebo groups in SARS-CoV-2 vaccine randomized trials: A systematic review","volume":"12","author":"Amanzio","year":"2022","journal-title":"Lancet Reg. Health Eur."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2400293","DOI":"10.2807\/1560-7917.ES.2025.30.1.2400293","article-title":"Monitoring SARS-CoV-2 variants with complementary surveillance systems: Risk evaluation of the Omicron JN. 1 variant in France, August 2023 to January 2024","volume":"30","author":"Traore","year":"2025","journal-title":"Eurosurveillance"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.ygeno.2020.09.059","article-title":"Genetics and genomics of SARS-CoV-2: A review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection","volume":"113","author":"Rahimi","year":"2021","journal-title":"Genomics"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/jama.2020.27124","article-title":"Genetic variants of SARS-CoV-2\u2014What do they mean?","volume":"325","author":"Lauring","year":"2021","journal-title":"JAMA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1038\/nm1143","article-title":"Severe acute respiratory syndrome","volume":"10","author":"Peiris","year":"2004","journal-title":"Nat. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0140-6736(03)13077-2","article-title":"Coronavirus as a possible cause of severe acute respiratory syndrome","volume":"361","author":"Peiris","year":"2003","journal-title":"Lancet"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.1085952","article-title":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome","volume":"300","author":"Rota","year":"2003","journal-title":"Science"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1126\/science.1085953","article-title":"The genome sequence of the SARS-associated coronavirus","volume":"300","author":"Marra","year":"2003","journal-title":"Science"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1126\/science.1087139","article-title":"Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China","volume":"302","author":"Guan","year":"2003","journal-title":"Science"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"14040","DOI":"10.1073\/pnas.0506735102","article-title":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats","volume":"102","author":"Lau","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1126\/science.1116480","article-title":"Structure of SARS coronavirus spike receptor-binding domain complexed with receptor","volume":"309","author":"Li","year":"2005","journal-title":"Science"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"7481","DOI":"10.1128\/JVI.00697-06","article-title":"Prevalence and genetic diversity of coronaviruses in bats from China","volume":"80","author":"Tang","year":"2006","journal-title":"J. Virol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1128\/JVI.02605-06","article-title":"Evolutionary insights into the ecology of coronaviruses","volume":"81","author":"Vijaykrishna","year":"2007","journal-title":"J. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"7863","DOI":"10.1128\/JVI.78.15.7863-7866.2004","article-title":"Severe acute respiratory syndrome coronavirus phylogeny: Toward consensus","volume":"78","author":"Gorbalenya","year":"2004","journal-title":"J. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"14909","DOI":"10.1128\/JVI.79.23.14909-14922.2005","article-title":"Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice","volume":"79","author":"Yount","year":"2005","journal-title":"J. Virol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"12540","DOI":"10.1073\/pnas.0605402103","article-title":"Severe acute respiratory syndrome-associated coronavirus 3a protein forms an ion channel and modulates virus release","volume":"103","author":"Lu","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0022-2836(03)00865-9","article-title":"Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage","volume":"331","author":"Snijder","year":"2003","journal-title":"J. Mol. Biol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Yang, Z. (2006). Computational Molecular Evolution, OUP Oxford.","DOI":"10.1093\/acprof:oso\/9780198567028.001.0001"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/viro.2002.1447","article-title":"Phylogenetic relationships and differential selection pressures among genotypes of dengue-2 virus","volume":"298","author":"Twiddy","year":"2002","journal-title":"Virology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1126\/science.1092002","article-title":"Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China","volume":"303","author":"Consortium","year":"2004","journal-title":"Science"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1073\/pnas.0409608102","article-title":"Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human","volume":"102","author":"Song","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Zhang, C.-Y., Wei, J.-F., and He, S.-H. (2006). Adaptive evolution of the spike gene of SARS coronavirus: Changes in positively selected sites in different epidemic groups. BMC Microbiol., 6.","DOI":"10.1186\/1471-2180-6-88"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.5808\/gi.20058","article-title":"Comparative study: Nonsynonymous and synonymous substitution of SARS-CoV-2, SARS-CoV, and MERS-CoV genome","volume":"19","author":"Sohpal","year":"2021","journal-title":"Genom. Inform."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5331","DOI":"10.1016\/j.ygeno.2020.11.003","article-title":"Trends of mutation accumulation across global SARS-CoV-2 genomes: Implications for the evolution of the novel coronavirus","volume":"112","author":"Roy","year":"2020","journal-title":"Genomics"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.1128\/JVI.02744-05","article-title":"Conformational states of the severe acute respiratory syndrome coronavirus spike protein ectodomain","volume":"80","author":"Li","year":"2006","journal-title":"J. Virol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Reinke, L.M., Spiegel, M., Plegge, T., Hartleib, A., Nehlmeier, I., Gierer, S., Hoffmann, M., Hofmann-Winkler, H., Winkler, M., and P\u00f6hlmann, S. (2017). Different residues in the SARS-CoV spike protein determine cleavage and activation by the host cell protease TMPRSS2. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0179177"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1126\/science.1118391","article-title":"Bats are natural reservoirs of SARS-like coronaviruses","volume":"310","author":"Li","year":"2005","journal-title":"Science"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.3201\/eid1212.060401","article-title":"Review of bats and SARS","volume":"12","author":"Wang","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Hatmal, M.m.M., Alshaer, W., Al-Hatamleh, M.A., Hatmal, M., Smadi, O., Taha, M.O., Oweida, A.J., Boer, J.C., Mohamud, R., and Plebanski, M. (2020). Comprehensive structural and molecular comparison of spike proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and their interactions with ACE2. Cells, 9.","DOI":"10.3390\/cells9122638"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/prot.25967","article-title":"Evolutionary relationships and sequence-structure determinants in human SARS coronavirus-2 spike proteins for host receptor recognition","volume":"88","author":"Guruprasad","year":"2020","journal-title":"Proteins Struct. Funct. Bioinform."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1073\/pnas.0500371102","article-title":"The power of phylogenetic comparison in revealing protein function","volume":"102","author":"Yang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1099\/0022-1317-82-6-1283","article-title":"Evidence for recombination in natural populations of dengue virus type 1 based on the analysis of complete genome sequences","volume":"82","author":"Tolou","year":"2001","journal-title":"J. Gen. Virol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"8904","DOI":"10.1074\/jbc.M111.325803","article-title":"Mechanisms of host receptor adaptation by severe acute respiratory syndrome coronavirus","volume":"287","author":"Wu","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.3201\/eid1112.041293","article-title":"SARS-CoV infection in a restaurant from palm civet","volume":"11","author":"Wang","year":"2005","journal-title":"Emerg. Infect. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.virusres.2007.03.012","article-title":"A review of studies on animal reservoirs of the SARS coronavirus","volume":"133","author":"Shi","year":"2008","journal-title":"Virus Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1001\/jama.2015.7646","article-title":"Middle East respiratory syndrome: A global health challenge","volume":"314","author":"Gostin","year":"2015","journal-title":"JAMA"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_57","first-page":"1693","article-title":"First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities\u2014May 2014","volume":"14","author":"Bialek","year":"2014","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1401505","article-title":"Evidence for camel-to-human transmission of MERS coronavirus","volume":"370","author":"Azhar","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3201\/eid2006.140299","article-title":"MERS coronaviruses in dromedary camels, Egypt","volume":"20","author":"Chu","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1000162","DOI":"10.4172\/2161-1068.1000162","article-title":"Incidence and mortality rate of Middle East respiratory syndrome-corona virus (MERS-Cov), threatens and opportunities","volume":"4","author":"Hussain","year":"2014","journal-title":"J. Mycobac Dis."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Zhou, H., Yang, J., Zhou, C., Chen, B., Fang, H., Chen, S., Zhang, X., Wang, L., and Zhang, L. (2021). A review of SARS-CoV2: Compared with SARS-CoV and MERS-CoV. Front. Med., 8.","DOI":"10.3389\/fmed.2021.628370"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"20596","DOI":"10.2807\/1560-7917.ES2013.18.39.20596","article-title":"Taking stock of the first 133 MERS coronavirus cases globally\u2013Is the epidemic changing?","volume":"18","author":"Penttinen","year":"2013","journal-title":"Eurosurveillance"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"20923","DOI":"10.2807\/1560-7917.ES2014.19.40.20923","article-title":"Laboratory capability and surveillance testing for Middle East respiratory syndrome coronavirus infection in the WHO European Region, June 2013","volume":"19","author":"Pereyaslov","year":"2014","journal-title":"Eurosurveillance"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"20828","DOI":"10.2807\/1560-7917.ES2014.19.23.20828","article-title":"Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity","volume":"19","author":"Hemida","year":"2014","journal-title":"Eurosurveillance"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Lee, J.Y., Kim, Y.-J., Chung, E.H., Kim, D.-W., Jeong, I., Kim, Y., Yun, M.-R., Kim, S.S., Kim, G., and Joh, J.-S. (2017). The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015. BMC Infect. Dis., 17.","DOI":"10.1186\/s12879-017-2576-5"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12985-016-0544-0","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV) origin and animal reservoir","volume":"13","author":"Mohd","year":"2016","journal-title":"Virol. J."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/tbed.12401","article-title":"Dromedary camels and the transmission of Middle East respiratory syndrome coronavirus (MERS-CoV)","volume":"64","author":"Hemida","year":"2017","journal-title":"Transbound. Emerg. Dis."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(15)60454-8","article-title":"Middle East respiratory syndrome","volume":"386","author":"Zumla","year":"2015","journal-title":"Lancet"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1586\/14760584.2016.1167603","article-title":"Vaccines for the prevention against the threat of MERS-CoV","volume":"15","author":"Du","year":"2016","journal-title":"Expert. Rev. Vaccines"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"101520","DOI":"10.1016\/j.tmaid.2019.101520","article-title":"MERS-CoV as an emerging respiratory illness: A review of prevention methods","volume":"32","author":"Baharoon","year":"2019","journal-title":"Travel. Med. Infect. Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1126\/science.aac8608","article-title":"Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia","volume":"351","author":"Sabir","year":"2016","journal-title":"Science"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Widagdo, W., Sooksawasdi Na Ayudhya, S., Hundie, G.B., and Haagmans, B.L. (2019). Host determinants of MERS-CoV transmission and pathogenesis. Viruses, 11.","DOI":"10.3390\/v11030280"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/14728222.2017.1271415","article-title":"MERS-CoV spike protein: A key target for antivirals","volume":"21","author":"Du","year":"2017","journal-title":"Expert. Opin. Ther. Targets"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Kim, J.I., Kim, Y.-J., Lemey, P., Lee, I., Park, S., Bae, J.-Y., Kim, D., Kim, H., Jang, S.-I., and Yang, J.-S. (2016). The recent ancestry of Middle East respiratory syndrome coronavirus in Korea has been shaped by recombination. Sci. Rep., 6.","DOI":"10.1038\/srep18825"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"11297","DOI":"10.1128\/JVI.01498-14","article-title":"Rooting the phylogenetic tree of middle East respiratory syndrome coronavirus by characterization of a conspecific virus from an African bat","volume":"88","author":"Corman","year":"2014","journal-title":"J. Virol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Sohrab, S.S., Alsaqaf, F., Hassan, A.M., Tolah, A.M., Bajrai, L.H., and Azhar, E.I. (2024). Genomic Diversity and Recombination Analysis of the Spike Protein Gene from Selected Human Coronaviruses. Biology, 13.","DOI":"10.3390\/biology13040282"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Forni, D., Filippi, G., Cagliani, R., De Gioia, L., Pozzoli, U., Al-Daghri, N., Clerici, M., and Sironi, M. (2015). The heptad repeat region is a major selection target in MERS-CoV and related coronaviruses. Sci. Rep., 5.","DOI":"10.1038\/srep14480"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/mBio.01062-13","article-title":"Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus","volume":"5","author":"Cotten","year":"2014","journal-title":"MBio"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Yamada, Y., Liu, X.B., Fang, S.G., Tay, F.P., and Liu, D.X. (2009). Acquisition of cell\u2013cell fusion activity by amino acid substitutions in spike protein determines the infectivity of a coronavirus in cultured cells. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0006130"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1128\/JVI.01674-07","article-title":"Amino acid substitutions in the S2 subunit of mouse hepatitis virus variant V51 encode determinants of host range expansion","volume":"82","author":"McRoy","year":"2008","journal-title":"J. Virol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"7629","DOI":"10.1128\/JVI.79.12.7629-7640.2005","article-title":"Murine coronavirus evolution in vivo: Functional compensation of a detrimental amino acid substitution in the receptor binding domain of the spike glycoprotein","volume":"79","author":"Hingley","year":"2005","journal-title":"J. Virol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1128\/JVI.02988-15","article-title":"Extensive positive selection drives the evolution of nonstructural proteins in lineage C betacoronaviruses","volume":"90","author":"Forni","year":"2016","journal-title":"J. Virol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.antiviral.2014.12.015","article-title":"The SARS-coronavirus papain-like protease: Structure, function and inhibition by designed antiviral compounds","volume":"115","author":"John","year":"2015","journal-title":"Antivir. Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species Severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","author":"Gorbalenya","year":"2020","journal-title":"Nat. Microbiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"438","DOI":"10.47102\/annals-acadmedsg.V36N6p438","article-title":"Pharmacologic treatment of SARS: Current knowledge and recommendations","volume":"36","author":"Tai","year":"2007","journal-title":"Ann. Acad. Med. Singap."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"100672","DOI":"10.1016\/j.nmni.2020.100672","article-title":"Epidemiology, genome, and clinical features of the pandemic SARS-CoV-2: A recent view","volume":"35","author":"Abduljalil","year":"2020","journal-title":"New Microbes New Infect."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.cmi.2020.03.026","article-title":"COVID-19, SARS and MERS: Are they closely related?","volume":"26","author":"Petrosillo","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_89","first-page":"S118","article-title":"Tracing the SARS-coronavirus","volume":"5","author":"Chan","year":"2013","journal-title":"J. Thorac. Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.coviro.2014.01.010","article-title":"MERS: Emergence of a novel human coronavirus","volume":"5","author":"Raj","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"ref_91","first-page":"2012","article-title":"Novel coronavirus 2019-nCoV: Prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV","volume":"24","author":"Meo","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jgar.2020.02.021","article-title":"2019 novel coronavirus (2019-nCoV) outbreak: A new challenge","volume":"21","author":"Lupia","year":"2020","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Yuan, M., Yin, W., Tao, Z., Tan, W., and Hu, Y. (2020). Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China. PLoS ONE, 15.","DOI":"10.1101\/2020.02.22.20024927"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Mahdy, M.A., Younis, W., and Ewaida, Z. (2020). An overview of SARS-CoV-2 and animal infection. Front. Vet. Sci., 7.","DOI":"10.3389\/fvets.2020.596391"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Prince, T., Smith, S.L., Radford, A.D., Solomon, T., Hughes, G.L., and Patterson, E.I. (2021). SARS-CoV-2 infections in animals: Reservoirs for reverse zoonosis and models for study. Viruses, 13.","DOI":"10.3390\/v13030494"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Zhao, J., Cui, W., and Tian, B.P. (2020). The Potential Intermediate Hosts for SARS-CoV-2. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.580137"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1007\/s00018-016-2299-6","article-title":"Mechanisms of viral mutation","volume":"73","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijid.2022.02.044","article-title":"SARS-CoV-2\u2019s high rate of genetic mutation under immune selective pressure: From oropharyngeal B.1.1.7 to intrapulmonary B.1.533 in a vaccinated patient","volume":"118","author":"Musso","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bbrc.2003.12.081","article-title":"A model of the ACE2 structure and function as a SARS-CoV receptor","volume":"314","author":"Prabakaran","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00408-020-00408-4","article-title":"ACE2: The major cell entry receptor for SARS-CoV-2","volume":"198","author":"Scialo","year":"2020","journal-title":"Lung"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"101160","DOI":"10.1016\/j.isci.2020.101160","article-title":"The MERS-CoV receptor DPP4 as a candidate binding target of the SARS-CoV-2 spike","volume":"23","author":"Li","year":"2020","journal-title":"Iscience"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.1016\/j.jmb.2020.07.009","article-title":"Mutations strengthened SARS-CoV-2 infectivity","volume":"432","author":"Chen","year":"2020","journal-title":"J. Mol. Biol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/bib\/bbaa233","article-title":"Systemic effects of missense mutations on SARS-CoV-2 spike glycoprotein stability and receptor-binding affinity","volume":"22","author":"Teng","year":"2021","journal-title":"Brief. Bioinform."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1021\/acsptsci.0c00113","article-title":"Can SARS-CoV-2 accumulate mutations in the S-protein to increase pathogenicity?","volume":"3","author":"Padhi","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/jmv.27331","article-title":"Molecular evolutionary characteristics of SARS-CoV-2 emerging in the United States","volume":"94","author":"Wang","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Wang, R., Hozumi, Y., Zheng, Y.-H., Yin, C., and Wei, G.-W. (2020). Host immune response driving SARS-CoV-2 evolution. Viruses, 12.","DOI":"10.3390\/v12101095"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1002\/jmv.27936","article-title":"Molecular aspects of Omicron, vaccine development, and recombinant strain XE: A review","volume":"94","author":"Akash","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41586-021-03944-y","article-title":"SARS-CoV-2 B. 1.617. 2 Delta variant replication and immune evasion","volume":"599","author":"Mlcochova","year":"2021","journal-title":"Nature"},{"key":"ref_109","unstructured":"Centres for Disease Control and Prevention (2025, June 12). COVID-19 Data Tracker, Available online: https:\/\/www.cdc.gov\/covid\/php\/variants\/variants-and-genomic-surveillance.html."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Thaweethai, T., Selvaggi, C.A., Ng, T.-C., Cheng, D., Cao, T., Chibnik, L.B., Shinnick, D.J., and Foulkes, A.S. (2025). Biomarker states and risk of death among individuals hospitalized with SARS-CoV-2 infection. BMC Infect. Dis., 25.","DOI":"10.1186\/s12879-025-10651-w"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abd4251","article-title":"Distinct conformational states of SARS-CoV-2 spike protein","volume":"369","author":"Cai","year":"2020","journal-title":"Science"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Elrobaa, I.H., and New, K.J. (2021). COVID-19: Pulmonary and extra pulmonary manifestations. Front. Public Health, 9.","DOI":"10.3389\/fpubh.2021.711616"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Zabidi, N.Z., Liew, H.L., Farouk, I.A., Puniyamurti, A., Yip, A.J.W., Wijesinghe, V.N., Low, Z.Y., Tang, J.W., Chow, V.T., and Lal, S.K. (2023). Evolution of SARS-CoV-2 variants: Implications on immune escape, vaccination, therapeutic and diagnostic strategies. Viruses, 15.","DOI":"10.3390\/v15040944"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Zhu, X., Mannar, D., Srivastava, S.S., Berezuk, A.M., Demers, J.-P., Saville, J.W., Leopold, K., Li, W., Dimitrov, D.S., and Tuttle, K.S. (2021). Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies. PLoS Biol., 19.","DOI":"10.1371\/journal.pbio.3001237"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Ahmed, W.S., Philip, A.M., and Biswas, K.H. (2022). Decreased interfacial dynamics caused by the N501Y mutation in the SARS-CoV-2 S1 spike: ACE2 complex. Biophys. J., 121.","DOI":"10.1101\/2021.01.07.425307"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"100086","DOI":"10.1016\/j.medidd.2021.100086","article-title":"The new SARS-CoV-2 strain shows a stronger binding affinity to ACE2 due to N501Y mutant","volume":"10","author":"Ali","year":"2021","journal-title":"Med. Drug Discov."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/s41591-022-01877-1","article-title":"Rapid evaluation of COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 variants by analysis of genetic distance","volume":"28","author":"Cao","year":"2022","journal-title":"Nat. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41579-022-00809-7","article-title":"SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies","volume":"21","author":"Cox","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Chen, L., He, Y., Liu, H., Shang, Y., and Guo, G. (2024). Potential immune evasion of the severe acute respiratory syndrome coronavirus 2 Omicron variants. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1339660"},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Focosi, D., Maggi, F., Franchini, M., McConnell, S., and Casadevall, A. (2022). Analysis of Immune Escape Variants from Antibody-Based Therapeutics against COVID-19: A Systematic Review. Int. J. Mol. Sci., 23.","DOI":"10.1101\/2021.11.11.21266207"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Saha, A., Ghosh Roy, S., Dwivedi, R., Tripathi, P., Kumar, K., Nambiar, S.M., and Pathak, R. (2025). Beyond the Pandemic Era: Recent Advances and Efficacy of SARS-CoV-2 Vaccines Against Emerging Variants of Concern. Vaccines, 13.","DOI":"10.3390\/vaccines13040424"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Tokhanbigli, S., Salami Ghaleh, S., Rahimian, K., Mahmanzar, M., Bayat, S., Ahangarzadeh, S., Moradi, B., Mahmanzar, R., Wang, Y., and Oliver, B.G.G. (2025). Intersecting SARS-CoV-2 spike mutations and global vaccine efficacy against COVID-19. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1435873"},{"key":"ref_126","first-page":"162","article-title":"SARS-CoV-2 variant biology: Immune escape, transmission and fitness","volume":"21","author":"Carabelli","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"101850","DOI":"10.1016\/j.xcrm.2024.101850","article-title":"Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunity","volume":"5","author":"Roederer","year":"2024","journal-title":"Cell Rep. Med."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1016\/S1473-3099(23)00744-2","article-title":"Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure","volume":"24","author":"Yang","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1038\/s41467-024-46490-7","article-title":"Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86\/JN.1 lineages combining increased fitness and antibody evasion","volume":"15","author":"Planas","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1016\/S1473-3099(23)00813-7","article-title":"Virological characteristics of the SARS-CoV-2 JN. 1 variant","volume":"24","author":"Kaku","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"e313","DOI":"10.1016\/S2666-5247(23)00373-7","article-title":"Characteristics of the SARS-CoV-2 omicron HK. 3 variant harbouring the FLip substitution","volume":"5","author":"Kosugi","year":"2024","journal-title":"Lancet Microbe"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"318","DOI":"10.21608\/jmals.2024.333814","article-title":"The COVID-19 JN.1 variant diagnosed in Egypt","volume":"5","author":"Yameny","year":"2023","journal-title":"J. Med. Life Sci."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0140-6736(20)31304-0","article-title":"Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): A population-based study","volume":"396","author":"Stringhini","year":"2020","journal-title":"Lancet"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"eabf1738","DOI":"10.1126\/sciadv.abf1738","article-title":"An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants","volume":"7","author":"Chan","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jiph.2021.12.011","article-title":"Isolation and characterization of SARS-CoV-2 Beta variant from UAE travelers","volume":"15","author":"Yadav","year":"2022","journal-title":"J. Infect. Public Health"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3201\/eid2704.210138","article-title":"Novel SARS-CoV-2 variant in travelers from Brazil to Japan","volume":"27","author":"Fujino","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/s41586-021-04245-0","article-title":"The N501Y spike substitution enhances SARS-CoV-2 infection and transmission","volume":"602","author":"Liu","year":"2022","journal-title":"Nature"},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Lu, L., Chu, A.W.-H., Zhang, R.R., Chan, W.-M., Ip, J.D., Tsoi, H.-W., Chen, L.-L., Cai, J.-P., Lung, D.C., and Tam, A.R. (2021). The impact of spike N501Y mutation on neutralizing activity and RBD binding of SARS-CoV-2 convalescent serum. EBioMedicine, 71.","DOI":"10.1016\/j.ebiom.2021.103544"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"103589","DOI":"10.1016\/j.isci.2021.103589","article-title":"Functional evaluation of the P681H mutation on the proteolytic activation of the SARS-CoV-2 variant B.1.1.7 (Alpha) spike","volume":"25","author":"Lubinski","year":"2022","journal-title":"Iscience"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1002\/jmv.27643","article-title":"The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 Omicron variant","volume":"94","author":"Tian","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1038\/s41467-021-25357-1","article-title":"Comprehensive mapping of SARS-CoV-2 interactions in vivo reveals functional virus-host interactions","volume":"12","author":"Yang","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"eabm4908","DOI":"10.1126\/scitranslmed.abm4908","article-title":"Characterization of the SARS-CoV-2 B. 1.621 (Mu) variant","volume":"14","author":"Halfmann","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41591-021-01285-x","article-title":"SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma","volume":"27","author":"Wibmer","year":"2021","journal-title":"Nat. Med."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","article-title":"Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies","volume":"602","author":"Cao","year":"2022","journal-title":"Nature"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-021-03398-2","article-title":"Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7","volume":"593","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"ref_146","unstructured":"(2021). Expression of Concern: Long non coding RNA FAM3D-AS1 inhibits development of colorectal cancer through NF-kB signaling pathway. Biosci. Rep., 41, BSR-20190724_EOC."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1002\/jmv.27062","article-title":"Preliminary report on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spike mutation T478K","volume":"93","author":"Mercatelli","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1002\/jmv.27927","article-title":"Omicron (BA.1) and sub-variants (BA.1.1, BA.2, and BA.3) of SARS-CoV-2 spike infectivity and pathogenicity: A comparative sequence and structural-based computational assessment","volume":"94","author":"Kumar","year":"2022","journal-title":"J. Med. Virol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/s41586-021-04266-9","article-title":"Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation","volume":"602","author":"Saito","year":"2022","journal-title":"Nature"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.chom.2021.06.006","article-title":"SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity","volume":"29","author":"Motozono","year":"2021","journal-title":"Cell Host Microbe"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41392-022-00941-z","article-title":"SARS-CoV-2 spike L452R mutation increases Omicron variant fusogenicity and infectivity as well as host glycolysis","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/JCM.00921-21","article-title":"Acquisition of the L452R mutation in the ACE2-binding interface of Spike protein triggers recent massive expansion of SARS-Cov-2 variants","volume":"59","author":"Tchesnokova","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Romero, P.E., D\u00e1vila-Barclay, A., Salvatierra, G., Gonz\u00e1lez, L., Cuicapuza, D., Sol\u00eds, L., Marcos-Carbajal, P., Huancachoque, J., Maturrano, L., and Tsukayama, P. (2021). The emergence of SARS-CoV-2 variant lambda (C.37) in South America. Microbiol. Spectr., 9.","DOI":"10.1128\/Spectrum.00789-21"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1002\/jmv.27235","article-title":"Introduction of SARS-COV-2 C. 37 (WHO VOI lambda) from Peru to Italy","volume":"93","author":"Baj","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41586-020-2895-3","article-title":"Spike mutation D614G alters SARS-CoV-2 fitness","volume":"592","author":"Plante","year":"2021","journal-title":"Nature"},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Alkhatib, M., Svicher, V., Salpini, R., Ambrosio, F.A., Bellocchi, M.C., Carioti, L., Piermatteo, L., Scutari, R., Costa, G., and Artese, A. (2021). SARS-CoV-2 variants and their relevant mutational profiles: Update summer 2021. Microbiol. Spectr., 9.","DOI":"10.1128\/Spectrum.01096-21"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41586-021-03461-y","article-title":"Bispecific IgG neutralizes SARS-CoV-2 variants and prevents escape in mice","volume":"593","author":"Pedotti","year":"2021","journal-title":"Nature"},{"key":"ref_158","first-page":"521","article-title":"Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution","volume":"614","author":"Cao","year":"2023","journal-title":"Nature"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"106861","DOI":"10.1016\/j.ijsu.2022.106861","article-title":"Could the new BA.2.75 sub-variant lead to another COVID-19 wave in the world?\u2014Correspondence","volume":"105","author":"Shaheen","year":"2022","journal-title":"Int. J. Surg."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"e416","DOI":"10.1016\/S1473-3099(24)00298-6","article-title":"Virological characteristics of the SARS-CoV-2 KP.2 variant","volume":"24","author":"Kaku","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/qjmed\/hcae102","article-title":"The emerging challenge of FLiRT variants: KP. 1.1 and KP. 2 in the global pandemic landscape","volume":"117","author":"Kumar","year":"2024","journal-title":"QJM Int. J. Med."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1515\/cclm-2024-0919","article-title":"Neutralizing antibodies against KP.2 and KP.3: Why the current vaccine needs an update","volume":"63","author":"Gillot","year":"2025","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"e482","DOI":"10.1016\/S1473-3099(24)00415-8","article-title":"Virological characteristics of the SARS-CoV-2 KP.3, LB.1, and KP.2.3 variants","volume":"24","author":"Kaku","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Chen, N., Decker, K.E., Schulz, S.R., Kempf, A., Nehlmeier, I., Moldenhauer, A.-S., Dopfer-Jablonka, A., Behrens, G.M., Stankov, M.V., and Manthey, L. (2024). Comparative Analysis of Host Cell Entry Efficiency and Neutralization Sensitivity of Emerging SARS-CoV-2 Lineages KP.2, KP.2.3, KP.3, and LB.1. Vaccines, 12.","DOI":"10.3390\/vaccines12111236"},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Hu, Y., Zou, J., Nguyen, M.D., Chang, H.C., Yeung, J., Hao, H., Shi, P.-Y., Ren, P., and Xie, X. (2025). Comparative analysis of replication and immune evasion among SARS-CoV-2 subvariants BA. 2.86, JN. 1, KP. 2, and KP. 3. mBio, 16.","DOI":"10.1128\/mbio.03503-24"},{"key":"ref_166","unstructured":"WHO (2025, June 12). SARS-CoV-2 Variant Trackers. Currently Circulating Variants Under Monitoring (VUMs) (as of 23 May 2025). Available online: https:\/\/www.who.int\/en\/activities\/tracking-SARS-CoV-2-variants\/g#:~:text=%23Excludes%20JN.,as%20of%2014%20April%202025."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1016\/S1473-3099(25)00007-6","article-title":"The KP.2-adapted COVID-19 vaccine improves neutralising activity against the XEC variant","volume":"25","author":"Suthar","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1080\/23744235.2024.2385500","article-title":"Features of the SARS-CoV-2 KP.3 variant mutations","volume":"56","author":"Branda","year":"2024","journal-title":"Infect. Dis."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1080\/23744235.2024.2391020","article-title":"On the new SARS-CoV-2 variant KP. 3.1. 1: Focus on its genetic potential","volume":"56","author":"Branda","year":"2024","journal-title":"Infect. Dis."},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Li, P., Faraone, J.N., Hsu, C.C., Chamblee, M., Liu, Y., Zheng, Y.-M., Xu, Y., Carlin, C., Horowitz, J.C., and Mallampalli, R.K. (2025). Neutralization and spike stability of JN. 1-derived LB.1, KP.2.3, KP.3, and KP.3.1. 1 subvariants. mBio, 16.","DOI":"10.1128\/mbio.00464-25"},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Aljabali, A.A., Lundstrom, K., Hromi\u0107-Jahjefendi\u0107, A., Abd El-Baky, N., Nawn, D., Hassan, S.S., Rubio-Casillas, A., Redwan, E.M., and Uversky, V.N. (2025). The XEC Variant: Genomic Evolution, Immune Evasion, and Public Health Implications. Viruses, 17.","DOI":"10.20944\/preprints202504.0496.v1"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"E193","DOI":"10.1016\/S1473-3099(25)00079-9","article-title":"Virological characteristics of the SARS-CoV-2 LP.8.1 variant","volume":"25","author":"Chen","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.1016\/S1473-3099(25)00356-1","article-title":"Virological characteristics of the SARS-CoV-2 NB. 1.8. 1 variant","volume":"25","author":"Uriu","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Feng, Z., Huang, J., Baboo, S., Diedrich, J.K., Bangaru, S., Paulson, J.C., Yates, J.R., Yuan, M., Wilson, I.A., and Ward, A.B. (2024). Structural and Functional Insights into the Evolution of SARS-CoV-2 KP.3.1.1 Spike Protein. bioRxiv.","DOI":"10.1101\/2024.12.10.627775"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"115543","DOI":"10.1016\/j.celrep.2025.115543","article-title":"Antibody evasiveness of SARS-CoV-2 subvariants KP.3.1.1 and XEC","volume":"44","author":"Wang","year":"2025","journal-title":"Cell Rep."},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Lugano, D., Kutima, B., Kimani, M., Sigilai, A., Gitonga, J., Karani, A., Akech, D., Karia, B., Ziraba, A.K., and Maina, A. (2024). Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya. BMC Infect. Dis., 24.","DOI":"10.1186\/s12879-024-10367-3"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/S1473-3099(24)00738-2","article-title":"Enhanced immune evasion of SARS-CoV-2 variants KP. 3.1. 1 and XEC through N-terminal domain mutations","volume":"25","author":"Liu","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"ref_178","unstructured":"Mutational Tracker (2025, June 12). GISAID Initiative. Available online: https:\/\/outbreak.info\/situation-reports?xmin=2024-12-12&xmax=2025-06-12&pango=JN.1.18.1."},{"key":"ref_179","unstructured":"Nextstrain Clade (2025, June 12). Genomic Epidemiology of SARS-CoV-2 with Clade-Focused Subsampling. Available online: https:\/\/nextstrain.org\/ncov\/gisaid\/global\/6m."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"e374","DOI":"10.1016\/S1473-3099(25)00308-1","article-title":"Antigenic and virological characteristics of SARS-CoV-2 variants BA. 3.2, XFG, and NB. 1.8. 1","volume":"25","author":"Guo","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"e012328","DOI":"10.1136\/bmjgh-2023-012328","article-title":"Severity and outcomes of Omicron variant of SARS-CoV-2 compared to Delta variant and severity of Omicron sublineages: A systematic review and metanalysis","volume":"8","author":"Relan","year":"2023","journal-title":"BMJ Glob. Health"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/10\/2450\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:31:04Z","timestamp":1760092264000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/10\/2450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":181,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["biomedicines13102450"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines13102450","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]}}}